Stem cells downregulate the elevated levels of tissue plasminogen activator in rats after spinal cord injury

Neurochemical Research

Volumn 34, Issue 7, 2009, Pages 1183-1194

  Veeravalli, Krishna Kumar ^a   Dasari, Venkata Ramesh ^a   Tsung, Andrew J ^a   Dinh, Dzung H ^a   Gujrati, Meena ^a   Fassett, Dan ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Myelin basic protein; Plasmin; Spinal cord injury; Spinal neurons; Stem cells; Tissue plasminogen activator

Indexed keywords

CYCLOSPORIN; GLUTAMIC ACID; HYDROGEN PEROXIDE; MESSENGER RNA; MYELIN BASIC PROTEIN; STAUROSPORINE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCULTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DENSITOMETRY; GRAFT REJECTION; HUMAN; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; SPINAL CORD NERVE CELL; ZYMOGRAPHY;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; CORD BLOOD STEM CELL TRANSPLANTATION; DOWN-REGULATION; HUMANS; MALE; NEURONS; RATS; RATS, INBRED LEW; SPINAL CORD INJURIES; STEM CELLS; TISSUE PLASMINOGEN ACTIVATOR; UP-REGULATION;

RATTUS;

EID: 67349256368     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9894-3     Document Type: Article

References (50)

1. Collen D (2001) Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. Hematology Am Soc Hematol Educ Program 1-9. doi: 10.1182/asheducation-2001.1.1
2. D Collen 1999 The plasminogen (fibrinolytic) system Thromb Haemost 82 259 270
3. D Collen HR Lijnen 1991 Basic and clinical aspects of fibrinolysis and thrombolysis Blood 78 3114 3124
4. T Masos R Miskin 1997 mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation Brain Res Mol Brain Res 47 157 169 10.1016/S0169-328X(97)00040-5
5. FJ Salles S Strickland 2002 Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus J Neurosci 22 2125 2134 (Pubitemid 35386512)
6. T Teesalu A Kulla A Simisker 2004 Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system Thromb Haemost 92 358 368 (Pubitemid 39172317)
7. M Yepes DA Lawrence 2004 New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system Exp Biol Med (Maywood) 229 1097 1104 (Pubitemid 39602251)
8. Z Qian ME Gilbert MA Colicos 1993 Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation Nature 361 453 457 10.1038/361453a0
9. M Zhuo DM Holtzman Y Li 2000 Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation J Neurosci 20 542 549 (Pubitemid 30225556)
10. CY Shin M Kundel DG Wells 2004 Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation J Neurosci 24 9425 9433 10.1523/JNEUROSCI.2457-04.2004
11. D Baranes D Lederfein YY Huang 1998 Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway Neuron 21 813 825 10.1016/S0896-6273(00)80597-8
12. A Gualandris TE Jones S Strickland 1996 Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator J Neurosci 16 2220 2225 (Pubitemid 26154333)
13. RJ Parmer M Mahata S Mahata 1997 Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA J Biol Chem 272 1976 1982 10.1074/jbc.272.3.1976
14. RN Pittman 1985 Release of plasminogen activator and a calcium-dependent metalloprotease from cultured sympathetic and sensory neurons Dev Biol 110 91 101 10.1016/0012-1606(85)90067-3
15. K Akassoglou KW Kombrinck JL Degen 2000 Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury J Cell Biol 149 1157 1166 10.1083/jcb.149.5.1157
16. LB Siconolfi NW Seeds 2001 Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush J Neurosci 21 4336 4347 (Pubitemid 32538559)
17. LB Siconolfi NW Seeds 2001 Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush J Neurosci 21 4348 4355 (Pubitemid 32538560)
18. YH Kim JH Park SH Hong 1999 Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator Science 284 647 650 10.1126/science.284.5414.647
19. W Cammer BR Bloom WT Norton 1978 Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination Proc Natl Acad Sci USA 75 1554 1558 10.1073/pnas.75.3.1554
20. AD Rogove C Siao B Keyt 1999 Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system J Cell Sci 112 Pt 22 4007 4016 (Pubitemid 30119770)
21. SE Tsirka A Gualandris DG Amaral 1995 Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator Nature 377 340 344 10.1038/377340a0
22. O Nicole F Docagne C Ali 2001 The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling Nat Med 7 59 64 10.1038/83358
23. ML Cuzner G Opdenakker 1999 Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system J Neuroimmunol 94 1 14 10.1016/S0165-5728(98)00241-0
24. PY Paterson CS Koh HC Kwaan 1987 Role of the clotting system in the pathogenesis of neuroimmunologic disease Fed Proc 46 91 96 (Pubitemid 17056327)
25. D Pitt P Werner CS Raine 2000 Glutamate excitotoxicity in a model of multiple sclerosis Nat Med 6 67 70 10.1038/71555
26. T Smith A Groom B Zhu 2000 Autoimmune encephalomyelitis ameliorated by AMPA antagonists Nat Med 6 62 66 10.1038/71548
27. CB Herbert GD Bittner JA Hubbell 1996 Effects of fibinolysis on neurite growth from dorsal root ganglia cultured in two- and three-dimensional fibrin gels J Comp Neurol 365 380 391 10.1002/(SICI)1096-9861(19960212)365:3<380:: AID-CNE4>3.0.CO;2-0
28. JH Uhm NP Dooley LY Oh 1998 Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix Glia 22 53 63 10.1002/(SICI)1098-1136(199801)22:1<53::AID-GLIA5>3. 0.CO;2-9
29. WG Bingham H Goldman SJ Friedman 1975 Blood flow in normal and injured monkey spinal cord J Neurosurg 43 162 171
30. W Young I Koreh 1986 Potassium and calcium changes in injured spinal cords Brain Res 365 42 53 10.1016/0006-8993(86)90720-1
31. AI Faden RP Simon 1988 A potential role for excitotoxins in the pathophysiology of spinal cord injury Ann Neurol 23 623 626 10.1002/ana. 410230618 (Pubitemid 18144392)
32. JR Wrathall YD Teng D Choiniere 1992 Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury Brain Res 586 140 143 10.1016/0006-8993(92)91384-Q
33. P Milvy S Kakari JB Campbell 1973 Paramagnetic species and radical products in cat spinal cord Ann N Y Acad Sci 222 1102 1111 10.1111/j.1749-6632. 1973.tb15327.x
34. NL Banik EL Hogan JM Powers 1986 Proteolytic enzymes in experimental spinal cord injury J Neurol Sci 73 245 256 10.1016/0022-510X(86)90149-8
35. JD Balentine 1978 Pathology of experimental spinal cord trauma II. Ultrastructure of axons and myelin Lab Invest 39 254 266 (Pubitemid 9025480)
36. JD Balentine C Hilton 1980 Ultrastructural pathology of axons and myelin in calcium-induced myelopathy J Neuropathol Exp Neurol 39 339
37. MJ Crowe JC Bresnahan SL Shuman 1997 Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys Nat Med 3 73 76 10.1038/nm0197-73
38. Y Abe H Nakamura O Yoshino 2003 Decreased neural damage after spinal cord injury in tPA-deficient mice J Neurotrauma 20 43 57 10.1089/08977150360517173 (Pubitemid 36176959)
39. VR Dasari DG Spomar CS Gondi 2007 Axonal remyelination by cord blood stem cells after spinal cord injury J Neurotrauma 24 391 410 10.1089/neu.2006.0142
40. VR Dasari DG Spomar L Li 2008 Umbilical cord blood stem cell mediated downregulation of Fas improves functional recovery of rats after spinal cord injury Neurochem Res 33 134 149 10.1007/s11064-007-9426-6
41. JA Gruner 1992 A monitored contusion model of spinal cord injury in the rat J Neurotrauma 9 123 126
42. M Ankarcrona JM Dypbukt E Bonfoco 1995 Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function Neuron 15 961 973 10.1016/0896-6273(95)90186-8
43. P Andrade-Gordon S Strickland 1986 Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen Biochemistry 25 4033 4040 10.1021/bi00362a007 (Pubitemid 16045626)
44. W Lu M Bhasin SE Tsirka 2002 Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis J Neurosci 22 10781 10789 (Pubitemid 36005152)
45. Y Katayama DP Becker T Tamura 1990 Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury J Neurosurg 73 889 900
46. JM Lee MC Grabb GJ Zipfel 2000 Brain tissue responses to ischemia J Clin Invest 106 723 731 10.1172/JCI11003
47. DW Choi 1987 Ionic dependence of glutamate neurotoxicity J Neurosci 7 369 379 (Pubitemid 17017466)
48. T Osterwalder J Contartese ET Stoeckli 1996 Neuroserpin, an axonally secreted serine protease inhibitor EMBO J 15 2944 2953 (Pubitemid 26188167)
49. F Akenami V Sirén M Koskiniemi 1996 Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases J Clin Pathol 49 577 580 (Pubitemid 26232734)
50. M Cuzner D Gveric C Strand 1996 The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution J Neuropathol Exp Neurol 55 1194 1204 (Pubitemid 26397138)